EAS 2016 Award Winners

​​​​young investigator award winners

  • ​Lukas Tomas, SwedenA lipid metabolite profile in atherosclerotic plaques associated with increased inflammation and cardiovascular risk
  • Francesca Vinch​i, GermanyIron accelerates cardiovascular disease: the importance of maintaining iron balance.

  • Laura D'Erasmo, ItalyResponse to treatment and occurrence of cardiovascular (cv) complications in patients with autosomal recessive hypercholesterolemia (ARH): A Retrospective Analysis

  • Monika Sharma, New ZealandCalcium dependent endocytosis and recycling of lipoprotein(a) in hepg2 cells

​best poster award

  • Barbara Kollerits, Austria PLASMA CONCENTRATIONS OF AFAMIN ARE ASSOCIATED WITH THE  PREVALENCE AND INCIDENCE OF TYPE 2 DIABETES MELLITUS
  • Julie Gall, France REDUCTION IN PLASMA CHOLESTEROL EFFLUX CAPACITY FROM HUMAN MACROPHAGES IS ASSOCIATED WITH THE APPEARANCE OF CLINICAL FEATURES OF METABOLIC SYNDROME
  • Jennifer J. Robinson, USAPHARMACODYNAMIC RELATIONSHIP BETWEEN PCSK9, ALIROCUMAB, AND LDL-C LOWERING IN FOUR PHASE 3 ODYSSEY TRIALS WITH/WITHOUT STATIN BACKGROUND
  • Stefano Manzini, ItalyHEPATIC MIRNA EXPRESSION PROFILING IN GENETICALLY MODIFIED MOUSE MODELS OF DIFFERENT ATHEROSCLEROSIS SUSCEPTIBILITY
  • Laura Michael, USA - GENETIC CORRELATIONS BETWEEN CIRCULATING MIRNAS AND LIPID PROFILES REVEAL NOVEL BIOMARKERS OF CVD RISK
  • Katrina Ellis, AustraliaThe prevalence of familial hyperlipidaemia and hyper-lipoprotein(a) in mutation-negative familial hypercholesterolaemia and associations with cardiovascular events
  • Núria Amigó, SpainPRO-ATHEROGENIC LIPOPROTEIN PROFILE ASSOCIATED WITH WHITE MATTER LESIONS IN CHRONIC KIDNEY DISEASE PATIENTS: A 1H-NMR METABOLOMIC APPROACH
  • James A. Goldstein, USACOMPOSITION OF CORONARY PLAQUES BY CT ANGIOGRAPHY: VALIDATION BY NEAR-INFRARED SPECTROSCOPY
  • Calvin Yeang, USAEXPRESSION OF E06, A NATURAL MONOCLONAL ANTIBODY TARGETED TO OXIDIZED PHOSPHOLIPIDS (OXPL), ATTENUATES THE PROGRESSION OF AORTIC SCLEROSIS IN AGED HYPERLIPIDEMIC MICE
  • Gloria Balzarotti, ItalyROLE OF PCSK9 (PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9) IN OBESITY AND METABOLIC SYNDROME: BEYOND LDLR TARGETING
  • Hsin-Yen Yang Yen, TaiwanIdentification of a novel apolipoprotein that facilitates MTP-mediated LIPID transport
  • Mike Petriello, USAPLASMA LEVELS OF THE PRO-ATHEROGENIC NUTRIENT BIOMARKER TMAO IS INCREASED BY EXPOSURE TO DIOXIN-LIKE POLLUTANTS THROUGH UPREGULATION OF FMO3
  • Josefa Girona, SpainPCSK9 CIRCULATING LEVELS AND CETP PLASMA ACTIVITY ARE ASSOCIATED INDEPENDENTLY OF LIPID LOWERING THERAPIES
  • Hyun Kook, Republic of KoreaMDM2 E3 LIGASE-mediated ubiquitination and degradation of HDAC1 in vascular calcification
  • Adrijana Kirsch, AustriaPONATINIB AUGMENTS VASOCONSTRICTION AND ATTENUATES VASORELAXATION IN MOUSE AORTIC RINGS
  • Dennis Wolf, GermanyACUTE EXPOSURE TO AIR POLLUTION AGGRAVATES ACUTE MYOCARDIAL INFARCTION AND SUBSEQUENT ISCHEMIC HEART FAILURE IN MICE​​
  • Laura Michael, USA - GENETIC CORRELATIONS BETWEEN CIRCULATING miRNAs AND LIPID PROFILES REVEAL NOVEL BIOMARKERS OF CVD RISK

Keep Me Updated